Upcoming Events
Breakthroughs in Healing: Psychedelics for Veterans with PTSD
Join the CPDRE for a critical seminar on the evolving landscape of veteran mental health. Led by Dr. Alan K. Davis, CPDRE researchers will present findings from the first FDA-regulated clinical trial investigating psilocybin-assisted therapy for the treatment of PTSD in military veterans at The Ohio State University.
Preliminary results indicate that approximately 75% of participants who completed the study met criteria for full remission of PTSD symptoms at the end of the trial, suggesting substantial therapeutic potential and supporting further investigation in controlled clinical settings.
Scan the QR code below for registration or visit our Eventbrite Page
Registration limited to 30 seats. Light refreshments provided.
Wed May 20, 2026 2:30pm – 4:30pm EDT (UTC -04:00)
Despite the surge of interest in psychedelic-assisted therapy over the past decade, transgender, nonbinary, and gender-expansive people have remained largely absent from psychedelic research and the questions most relevant to their lives have gone largely unasked.
In this talk, Rafaelle Lancelotta, a clinician-researcher and PhD candidate at Ohio State University's Center for Psychedelic Drug Research and Education, presents emerging research on how psychedelics may support gender identity exploration, self-acceptance, and mental health in LGBTQIA+ communities. Drawing on both quantitative survey data and qualitative interviews with transgender and gender-expansive psychedelic users, this work points toward something the clinical literature has been slow to take seriously: that psychedelics may offer people a profound and sometimes irreplaceable space to encounter who they truly are.
The talk will explore what the research does and doesn't tell us, what it means to hold that space ethically and with cultural humility, and why the freedom to explore one's own truth without a predetermined destination may be as important as any therapeutic outcome.
Followed by open discussion with the audience.
Sun May 31, 2026 2:00pm – 3:30pm EDT (UTC -04:00)
Exploring the most profound and least understood psychedelic experience on Earth
5-MeO-DMT is unlike anything else. Described by many who have taken it as the most intense and all-encompassing experience of their lives, it can produce a complete dissolution of the sense of self, leaving behind something that is difficult to put into words, and often impossible to forget.
Yet despite growing interest, it remains one of the least understood psychedelics in both scientific and public discourse.
So what do we actually know , and what does the research tell us about approaching it safely and meaningfully?
In this in-depth session, Dr. Alan Davis, one of the world's leading researcher at John Hopkins University, takes us beyond the mystery and into the evidence. Bridging neuroscience, subjective experience, and real-world safety considerations, this talk offers a grounded and accessible exploration for anyone curious about 5-MeO-DMT.
The session will open with a presentation by Dr. Davis, followed by a live Q&A with the audience.
Indigenous Communities and Psychedelic Medicines
Please join the CPDRE and the CBSC for this event, taking place on Thursday, November 9th at 6:00pm in Stillman Hall 100 on OSU’s Main Campus.
Panelists include:
Dawn Davis: A mother, a wife, CEO of NativeSci LLC, co-editor of the Journal of Native Sciences, a founding member of Source Research Foundation, a Newe and a citizen of the Shoshone-Bannock Tribes. Dawn is an Indigenous Researcher and educator with a PhD in Natural Resources and Water Resources. Her research has focused on Peyote [Lophophora williamsii] decline and conservation efforts since 2006. Dawn has shared her research among Indigenous, academic, ethnobotanical, and psychedelic audiences nationally and internationally.
Mariah Delmindo-Moore: An Independently Licensed Chemical Dependency Counselor with both a Gambling Treatment and Clinical Supervision endorsement from the state of Ohio. Mariah's educational accomplishments includes both a Bachelor's and Master's in the field of Psychology, a Post-Masters certificate in Teaching Psychology, and has completed her Doctoral coursework for her PhD in Psychology at Walden University. Mariah has over thirty years of experience in the field of human services.
Rafaelle Lancelotta: A PhD student at The Ohio State University College of Social Work studying the importance of human relationship in psychedelic therapy interventions. They received their Master's degree in Mental Health Counseling from the University of Wyoming and worked for several years as a somatic-focused, trauma-informed counselor who has supported clients use of cannabis and ketamine to enhance the therapeutic process. They are passionate about increasing accessibility and responsible clinical applications of psychedelics/entheogens for under-represented populations.
“How to Change Your Mind” with the CPDRE
To celebrate its official opening this summer, the Center will be screening an Episode of the Netflix docuseries “How to Change Your Mind”, which focuses on the history and therapeutic potential of psilocybin. The screening will be followed by a Q&A with the Center’s director, Dr. Alan Davis. The event will take place on October 20th from 7-9 pm on Campus in Meiling Hall 160. Tickets are $5 and all proceeds will go towards funding future research at the Center. Click the button below for further details and to purchase tickets.